PTC Therapeutics, Inc.

US$65.44As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PTCTHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 26.49%
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.51
PE TTM —
TSR TTM (4.20%)
Mkt cap US$5.467B
ROIC 10.12%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$73
11.26%
(96.26%)
Hold 5|7|4|8|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.09
1.11
1.17
1.30
14.04%
17.20%
24.84%
25.83%
Revenue$M
270.4
266.1
274.0
273.0
6.32%
(0.03%)
2.33%
(0.09%)
Peers (US$5.467B)
Cap (US$)
PE
5.487B
84.56x
Capital
TTM
5Y
10Y
Leveragex
6.835
0.027
0.027
EBIT/Intx
0.123
0.750
0.591
Own earn%
(84.60)
(166.75)
(170.71)
Sh yield%
43.49
32.54
33.52
Owners
Insiders/Inst%
9.74
76.76
Short interest%
0.82
SBC / revenue%
5.01
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
12–19
$1 testx
—
Incr. ROIC%
15